TFTakeru Fukunaga

Takeru Fukunaga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takeru Fukunaga has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Chie Inoue

    Division of Radiology, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori, 683-8504, Japan

    2 shared publications
  • Naoko Mukuda

    Division of Radiology, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University

    2 shared publications
  • Shinya Fujii

    Division of Radiology, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori, 683-8504, Japan

    2 shared publications
  • Toshihide Ogawa

    Division of Radiology, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori, 683-8504, Japan

    2 shared publications
  • Atsushi Murakami

    Department of Radiology, Yoka Hospital, 1878-1 Yoka-cho Yoka, Yabu, Hyogo, 667-8555, Japan

    1 shared publication
  • Ayumi Kato

    Division of Radiology, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University, Yonago, Japan

    1 shared publication

Latest Publications

  • Open Access

    A Small Granulosa Cell Tumor of the Ovary Incidentally Detected on Diffusion-weighted Images

    by Chie Inoue, Shinya Fujii, Kanae Nosaka, Naoko Mukuda, Takeru Fukunaga, Toshihide Ogawa

    Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies


  • The spectrum of imaging appearances of müllerian duct anomalies: focus on MR imaging

    by Takeru Fukunaga, Shinya Fujii, Chie Inoue, Naoko Mukuda, Atsushi Murakami, Yoshio Tanabe, Tasuku Harada, Toshihide Ogawa

    Müllerian duct anomalies (MDAs) are the result of incomplete development, vertical or lateral fusion, or absorption of the müllerian ducts. The range of anomalies includes uterovaginal agenesis or hypoplasia, unicornuate uterus, uterus didelphys, bicornuate uterus, septate uterus, and arcuate uterus. Correct diagnosis and classification of these anomalies are essential because pregnancy outcomes and treatment options vary between the types of anomaly. Furthermore, early identification of MDAs helps to avoid prolonged symptomatic periods and the complications that may subsequently arise, such as infertility, endometriosis, and neoplasm. Although many of these abnormalities are initially diagnosed by ultrasound or hysterosalpingography, MR imaging is the most accurate noninvasive modality available for classification of the various anomalies because of its better anatomic assessment compared with other diagnostic modalities. Familiarity with the wide variety of MDA presentations can help in the planning of appropriate treatment.


  • Open Access

    Accuracy of semiquantitative dynamic contrast‐enhanced MRI for differentiating type II from type I endometrial carcinoma

    by Takeru Fukunaga, Shinya Fujii, Chie Inoue, Ayumi Kato, Jun Chikumi, Toshio Kaminou, Toshihide Ogawa

    Purpose: To investigate type II endometrial carcinoma characterization using dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) and evaluate the diagnostic accuracy of semiquantitative DCE‐MRI in differentiating type II from type I tumors.Materials and Methods: Seventy‐seven patients with endometrial carcinoma were retrospectively evaluated using 3T DCE‐MRI. The maximum absolute enhancement of signal intensity (SImax), maximum relative enhancement (SIrel), wash‐in rate (WIR), and the SImax/SI (piriformis) ratio were analyzed. To differentiate type I from type II tumors, optimal threshold criteria were established. The Mann–Whitney U‐test was used for statistical comparison and receiver operating characteristic curve analysis was used to determine optimal cutoff values.Results: The SIrel (P < 0.001), WIR (P < 0.0001), and SImax/SI (piriformis) ratio (P < 0.0001), but not SImax, differed significantly between type I and type II carcinomas. Cutoff values of SIrel ≥58.8, WIR ≥37.0, and SImax/SI (piriformis) ratio ≥1.55 had sensitivities of 93%, 93%, and 67%, specificities of 60%, 60%, and 79%, accuracies of 66%, 66%, and 67%, respectively, for predicting type II endometrial carcinoma.Conclusion: Endometrial carcinoma with strong (high level) enhancement on DCE‐MRI is suggestive of type II endometrial carcinoma. Semiquantitative evaluation of DCE‐MRI may be useful for differentiating type II from type I tumors. J. Magn. Reson. Imaging 2015;41:1662–1668. © 2014 Wiley Periodicals, Inc.